1 Safety Screening Centre, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Alderley Park, Macclesfield, UK.
2 Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, Queen's Medical Centre, University of Nottingham, Nottingham, UK.
SLAS Discov. 2018 Feb;23(2):211-217. doi: 10.1177/2472555217740576. Epub 2017 Oct 26.
Three-dimensional (3D) in vitro microphysiological cultures, such as spheroids and organoids, promise increased patient relevance and therapeutic predictivity compared with reductionist cell monolayers. However, high-throughput characterization techniques for 3D models are currently limited to simplistic live/dead assays. By sectioning and staining in vitro microtissues, researchers can examine their structure; detect DNA, RNA, and protein targets; and visualize them at the level of single cells. The morphological examination and immunochemistry staining for in vitro cultures has historically been done in a laborious manner involving testing one set of cultures at a time. We have developed a technology to rapidly screen spheroid phenotype and protein expression by arranging 66 spheroids in a gel array for paraffin embedding, sectioning, and immunohistochemsitry. The process is quick, mostly automatable, and uses 11 times less reagents than conventional techniques. Here we showcase the capabilities of the technique in an array made up of 11 different cell lines stained in conventional hematoxylin and eosin (H&E) staining, as well as immunohistochemistry staining for estrogen (ER), progesterone (PR), and human epidermal growth factor (Her-2) receptors, and TP53. This new methodology can be used in optimizing stem cell-based models of disease and development, for tissue engineering, safety screening, and efficacy screens in cancer research.
三维(3D)体外微生理培养物,如球体和类器官,与简化的单层细胞相比,有望提高患者相关性和治疗预测性。然而,目前用于 3D 模型的高通量表征技术仅限于简单的死活检测。通过对体外微组织进行切片和染色,研究人员可以检查其结构;检测 DNA、RNA 和蛋白质靶标;并在单细胞水平上对其进行可视化。体外培养物的形态学检查和免疫组织化学染色在历史上是通过一次测试一组培养物的繁琐方式进行的。我们开发了一种技术,可以通过将 66 个球体排列在凝胶阵列中进行石蜡包埋、切片和免疫组织化学染色,快速筛选球体表型和蛋白质表达。该过程快速、大部分可自动化,并且比传统技术少使用 11 倍的试剂。在这里,我们展示了该技术在由 11 种不同细胞系组成的阵列中的功能,这些细胞系经过传统的苏木精和伊红(H&E)染色以及雌激素(ER)、孕激素(PR)和人表皮生长因子(Her-2)受体以及 TP53 的免疫组织化学染色。这种新方法可用于优化基于干细胞的疾病和发育模型、组织工程、安全筛选以及癌症研究中的疗效筛选。